Jul 14, 2021, 12:21 PM by

Jul 14, 2021, 12:21 PM by

Jul 14, 2021, 12:21 PM by

Verichem’s MATRIX PLUS™ Chemistry Reference Kit is expressly intended to support overall system QC and CLIA compliance within the clinical laboratory.

Jul 14, 2021, 12:20 PM by

FDS Amplicare Awards $25,000 Grant to CPESN Minnesota to Help 50 Community Pharmacies Expand Healthcare Services

Jul 14, 2021, 12:20 PM by

Flywheel and HealthMyne: Combined technology solution to accelerate radiomics research and clinical trial outcomes

Jul 14, 2021, 12:20 PM by

Survey of >100 health plan leaders offers insight into the challenges of balancing prospective and retrospective approaches across enterprise payment integrity programs

Jul 14, 2021, 12:20 PM by

Standigm Inc. (“Standigm”), a leading workflow artificial intelligence (AI) drug discovery company, and SK Chemicals Co., Ltd (“SK Chemicals”), a life science and green chemicals company, announced today that they have signed a strategic partnership contract for collaboration regarding clinical development of Standigm’s AI-driven drug candidate for non-alcoholic steatohepatitis (“NASH”) and the foundation of Standigm’s Synthesis Research Center within the headquarters of SK Chemicals. This partnership was made in conjunction with SK Chemicals’ participation in Standigm’s pre-IPO round of fundraising.

Jul 14, 2021, 12:20 PM by

Jul 13, 2021, 12:21 PM by User Not Found

Bio-IT World | Strateos has launched its SmartLab Software which enables research organizations of any size to manage scientific workflows in-house while integrating automation with a modular, cloud-based software platform.

Jul 8, 2021, 01:00 AM by User Not Found

Bio-IT World | In at least two, placebo-controlled randomized trials getting underway in the next year, participants will be purposefully infected with a strain of group A streptococcus (Strep A) causing acute pharyngitis (strep throat) in a human challenge test of candidate vaccines intended to confer protection.

Jul 7, 2021, 01:00 AM by User Not Found

Bio-IT World | As part of regulatory submissions commercial labs are required to demonstrate that their clonal-derivation process is sound and that the high-value master cell submitted, did indeed, start from a single cell. Process validation (is the process fit for purpose?) and subsequent verification (is the process still fit for purpose?) becomes the backbone of clonal assurance.

Jul 6, 2021, 01:00 AM by User Not Found

Bio-IT World | A trio of universities are putting their heads together to engineer a wirelessly controlled bioelectronic implant intended to help soldiers adapt to new time zones or drastic changes in their work schedules by releasing peptide-based therapies to harmonize their central and peripheral circadian clocks.

Jul 1, 2021, 16:59 PM by

VERICHEM now offers clinical laboratorians an extensive line of liquid stable and ready-to-use biosynthetic clinical reference materials for urine chemistry assays.

Jul 1, 2021, 16:59 PM by

ZEISS introduces unique digitization system for virtual microscopy, collaboration and machine learning data analytics

Jul 1, 2021, 16:59 PM by

Genezen Laboratories, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, vector production and analytical testing services, has broken ground on a new multiphase master plan for a 75,000+ square foot cGMP-compliant Lentiviral vector production facility.

Jul 1, 2021, 16:59 PM by

Jul 1, 2021, 16:59 PM by

Jul 1, 2021, 16:59 PM by

The Verisense IMU (inertial measurement unit) was the first Shimmer sensor validated following the V3 framework championed by the Digital Medicine Society (DiMe).

Jul 1, 2021, 16:59 PM by

Watson-Marlow Fluid Technology Group announces it has been named winner of the Best Employer category at the 2021 Best Business Awards.

Jul 1, 2021, 16:59 PM by

Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization (CDMO), published its first annual sustainability report, consolidating the company’s policies for an enhanced ESG management system and related plans. The report focuses on the company’s commitment to taking part in social responsibility over the past decade and its future plans for the next ten years and beyond.